{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:24:39Z","timestamp":1788175479844,"version":"build-2803163510"},"reference-count":63,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.prro.2026.03.015","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:03:01Z","timestamp":1777593781000},"page":"e413-e421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Adaptive Salvage Stereotactic Radiation for Locoregional Recurrence of Pancreatic Adenocarcinoma After Surgery"],"prefix":"10.1016","volume":"16","author":[{"given":"David S.","family":"Lakomy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Padgett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylie","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer","family":"Sager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bita","family":"Kalaghchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roheena","family":"Panni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Sanford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Grierson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kian-Huat","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"DeNardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"DeSelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Richard","family":"Waters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4029-8764","authenticated-orcid":false,"given":"Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2026.03.015_bib0001","first-page":"118","article-title":"Cancers with increasing incidence trends in the United States: 1999 through 2008","volume":"62","author":"Simard","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.prro.2026.03.015_bib0002","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/cncr.27514","article-title":"Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity","volume":"118","author":"Eheman","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2026.03.015_bib0003","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1200\/JCO.2008.20.8983","article-title":"Future of cancer incidence in the United States: Burdens upon an aging, changing nation","volume":"27","author":"Smith","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2026.03.015_bib0004","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.prro.2026.03.015_bib0005","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/01.sla.0000245845.06772.7d","article-title":"Surgery for recurrent pancreatic ductal adenocarcinoma","volume":"245","author":"Kleeff","year":"2007","journal-title":"Ann Surg"},{"key":"10.1016\/j.prro.2026.03.015_bib0006","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/SLA.0000000000002234","article-title":"Patterns, timing, and predictors of recurrence following pancreatectomy for pancreatic ductal adenocarcinoma","volume":"267","author":"Groot","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.prro.2026.03.015_bib0007","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1001\/jamasurg.2019.3337","article-title":"Patterns of recurrence after resection of pancreatic ductal adenocarcinoma: A secondary analysis of the ESPAC-4 randomized adjuvant chemotherapy trial","volume":"154","author":"Jones","year":"2019","journal-title":"JAMA Surg"},{"key":"10.1016\/j.prro.2026.03.015_bib0008","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1053\/j.gastro.2024.05.028","article-title":"Prognostic factors for early recurrence after resection of pancreatic cancer: A systematic review and meta-analysis","volume":"167","author":"Leonhardt","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.prro.2026.03.015_bib0009","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s002689900215","article-title":"Recurrence after resection for ductal adenocarcinoma of the pancreas","volume":"21","author":"Sperti","year":"1997","journal-title":"World J Surg"},{"key":"10.1016\/j.prro.2026.03.015_bib0010","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.ejso.2008.12.006","article-title":"Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma","volume":"35","author":"Van den Broeck","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.prro.2026.03.015_bib0011","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.gassur.2005.09.016","article-title":"Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings","volume":"10","author":"Hishinuma","year":"2006","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.prro.2026.03.015_bib0012","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1002\/1097-0142(19931001)72:7<2118::AID-CNCR2820720710>3.0.CO;2-4","article-title":"An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging","volume":"72","author":"Kayahara","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2026.03.015_bib0013","doi-asserted-by":"crossref","first-page":"711","DOI":"10.6004\/jnccn.2018.7013","article-title":"Clinical impact of local progression in pancreatic cancer","volume":"16","author":"Cardillo","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.prro.2026.03.015_bib0014","first-page":"343","article-title":"Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: Experience from two institutions","volume":"4","author":"Wild","year":"2013","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.prro.2026.03.015_bib0015","doi-asserted-by":"crossref","first-page":"283","DOI":"10.7150\/jca.13295","article-title":"Stereotactic body radiotherapy (SBRT) reirradiation for recurrent pancreas cancer","volume":"7","author":"Dagoglu","year":"2016","journal-title":"J Cancer"},{"key":"10.1016\/j.prro.2026.03.015_bib0016","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1245\/s10434-017-6134-6","article-title":"Stereotactic body radiation therapy for isolated local recurrence after surgical resection of pancreatic ductal adenocarcinoma appears to be safe and effective","volume":"25","author":"Ryan","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.prro.2026.03.015_bib0017","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ejso.2016.12.012","article-title":"Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery: A retrospective study","volume":"43","author":"Comito","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.prro.2026.03.015_bib0018","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.clon.2021.12.014","article-title":"Efficacy and safety of reirradiation with stereotactic body radiation therapy for locally recurrent pancreatic adenocarcinoma","volume":"34","author":"Reddy","year":"2022","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.prro.2026.03.015_bib0019","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.ijrobp.2003.11.004","article-title":"Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer","volume":"58","author":"Koong","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2026.03.015_bib0020","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ijrobp.2005.07.002","article-title":"Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer","volume":"63","author":"Koong","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2026.03.015_bib0021","doi-asserted-by":"crossref","first-page":"e615","DOI":"10.1016\/j.ijrobp.2011.04.045","article-title":"Induction gemcitabine and stereotactic body radiotherapy for locally advanced nonmetastatic pancreas cancer","volume":"81","author":"Mahadevan","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2026.03.015_bib0022","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ijrobp.2008.01.051","article-title":"Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer","volume":"72","author":"Schellenberg","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2026.03.015_bib0023","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/cncr.24059","article-title":"Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas","volume":"115","author":"Chang","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2026.03.015_bib0024","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.radonc.2004.12.022","article-title":"Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma","volume":"76","author":"Hoyer","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2026.03.015_bib0025","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ijrobp.2016.10.030","article-title":"Stereotactic body radiation therapy for locally advanced pancreatic cancer: A systematic review and pooled analysis of 19 trials","volume":"97","author":"Petrelli","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2026.03.015_bib0026","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/cncr.29161","article-title":"Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma","volume":"121","author":"Herman","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.prro.2026.03.015_bib0027","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.3390\/jcm13092631","article-title":"Salvage ablative radiotherapy for isolated local recurrence of pancreatic adenocarcinoma following definitive surgery","volume":"13","author":"Dee","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.prro.2026.03.015_bib0028","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.3109\/0284186X.2015.1062541","article-title":"Comparison of onboard low-field magnetic resonance imaging versus onboard computed tomography for anatomy visualization in radiotherapy","volume":"54","author":"Noel","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.prro.2026.03.015_bib0029","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ijrobp.2016.08.036","article-title":"Simulated online adaptive magnetic resonance\u2013guided stereotactic body radiation therapy for the treatment of oligometastatic disease of the abdomen and central thorax: Characterization of potential advantages","volume":"96","author":"Henke","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2026.03.015_bib0030","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.adro.2018.10.003","article-title":"Stereotactic MR-guided online adaptive radiation therapy (SMART) for ultracentral thorax malignancies: Results of a phase 1 trial","volume":"4","author":"Henke","year":"2019","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.prro.2026.03.015_bib0031","doi-asserted-by":"crossref","first-page":"e298","DOI":"10.1016\/j.prro.2018.12.004","article-title":"Delineation of a cardiac planning organ-at-risk volume using real-time magnetic resonance imaging for cardiac protection in thoracic and breast radiation therapy","volume":"9","author":"Henke","year":"2019","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2026.03.015_bib0032","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.adro.2018.08.005","article-title":"A multi-institutional experience of MR-guided liver stereotactic body radiation therapy","volume":"4","author":"Rosenberg","year":"2019","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.prro.2026.03.015_bib0033","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1002\/cam4.2100","article-title":"Using adaptive magnetic resonance image-guided radiation therapy for treatment of inoperable pancreatic cancer","volume":"8","author":"Rudra","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.prro.2026.03.015_bib0034","article-title":"Ablative five-fraction stereotactic body radiation therapy for inoperable pancreatic cancer using online MR-guided adaptation","volume":"6","author":"Hassanzadeh","year":"2021","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.prro.2026.03.015_bib0035","article-title":"Understanding the impact of radiation-induced lymphopenia: Preclinical and clinical research perspectives","volume":"49","author":"Prades-Sagarra","year":"2024","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.prro.2026.03.015_bib0036","article-title":"Financial toxicity in radiation oncology: Impact for our patients and for practicing radiation oncologists","volume":"9","author":"Wu","year":"2023","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.prro.2026.03.015_bib0037","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ijrobp.2015.10.015","article-title":"Online magnetic resonance image guided adaptive radiation therapy: First clinical applications","volume":"94","author":"Acharya","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2026.03.015_bib0038","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.radonc.2017.11.032","article-title":"Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen","volume":"126","author":"Henke","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2026.03.015_bib0039","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.prro.2026.03.015_bib0040","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.21037\/jgo-22-38","article-title":"Stereotactic body radiation therapy for the treatment of locally recurrent pancreatic cancer after surgical resection","volume":"13","author":"Reddy","year":"2022","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.prro.2026.03.015_bib0041","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJMra0901557","article-title":"Pancreatic cancer","volume":"362","author":"Hidalgo","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prro.2026.03.015_bib0042","doi-asserted-by":"crossref","first-page":"19","DOI":"10.21037\/cco-21-87","article-title":"Treatment for postoperative recurrence of pancreatic cancer: A narrative review","volume":"11","author":"Okusaka","year":"2022","journal-title":"Chin Clin Oncol"},{"key":"10.1016\/j.prro.2026.03.015_bib0043","doi-asserted-by":"crossref","first-page":"315","DOI":"10.14701\/ahbps.24-041","article-title":"Meta-analysis of pancreatic re-resection for locally recurrent pancreatic cancer following index pancreatectomy","volume":"28","author":"Hajibandeh","year":"2024","journal-title":"Ann Hepatobiliary Pancreat Surg"},{"key":"10.1016\/j.prro.2026.03.015_bib0044","first-page":"34","article-title":"Combined chemoradiotherapy for isolated local recurrence after primary resection of pancreatic cancer","volume":"7","author":"Wilkowski","year":"2006","journal-title":"JOP"},{"key":"10.1016\/j.prro.2026.03.015_bib0045","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1748-717X-8-27","article-title":"Chemoradiation in patients with isolated recurrent pancreatic cancer - therapeutical efficacy and probability of re-resection","volume":"8","author":"Habermehl","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.prro.2026.03.015_bib0046","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00066-014-0610-8","article-title":"Radiotherapy for patients with isolated local recurrence of primary resected pancreatic cancer. Prolonged disease-free interval associated with favorable prognosis","volume":"190","author":"Nakamura","year":"2014","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.prro.2026.03.015_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.110064","article-title":"Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancreatic cancer: A multi-center, open-label phase 2 study","volume":"191","author":"Chuong","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2026.03.015_bib0048","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1748-717X-7-74","article-title":"Stereotactic body radiation therapy for reirradiation of localized adenocarcinoma of the pancreas","volume":"7","author":"Lominska","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.prro.2026.03.015_bib0049","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.adro.2017.01.003","article-title":"Reirradiation with stereotactic body radiation therapy after prior conventional fractionation radiation for locally recurrent pancreatic adenocarcinoma","volume":"2","author":"Koong","year":"2017","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.prro.2026.03.015_bib0050","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fonc.2018.00052","article-title":"Stereotactic body radiation therapy for locally progressive and recurrent pancreatic cancer after prior radiation","volume":"8","author":"Sutera","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.prro.2026.03.015_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2020.100818","article-title":"Analysis of the efficacy, safety and survival factors of stereotactic body radiation therapy in patients with recurrence of pancreatic cancer","volume":"13","author":"Li","year":"2020","journal-title":"Transl Oncol"},{"key":"10.1016\/j.prro.2026.03.015_bib0052","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S1470-2045(22)00066-3","article-title":"Stereotactic body radiotherapy plus pembrolizumab and trametinib versus stereotactic body radiotherapy plus gemcitabine for locally recurrent pancreatic cancer after surgical resection: An open-label, randomised, controlled, phase 2 trial","volume":"23","author":"Zhu","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2026.03.015_bib0053","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ejso.2012.04.007","article-title":"Appraisal of a total meso-pancreatoduodenum excision with pancreaticoduodenectomy for pancreatic head carcinoma","volume":"38","author":"Kawabata","year":"2012","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.prro.2026.03.015_bib0054","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ejso.2011.12.015","article-title":"Surgical technique and results of total mesopancreas excision (TMpE) in pancreatic tumors","volume":"38","author":"Adham","year":"2012","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.prro.2026.03.015_bib0055","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.hpb.2017.07.007","article-title":"The TRIANGLE operation \u2013 radical surgery after neoadjuvant treatment for advanced pancreatic cancer: A single arm observational study","volume":"19","author":"Hackert","year":"2017","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.prro.2026.03.015_bib0056","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.prro.2022.01.005","article-title":"Location, location, location: What should be targeted beyond gross disease for localized pancreatic ductal adenocarcinoma? Proposal of a standardized clinical tumor volume for pancreatic ductal adenocarcinoma of the head: The \u201ctriangle volume.\u201d","volume":"12","author":"Hill","year":"2022","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2026.03.015_bib0057","article-title":"Patterns of failure in patients with borderline resectable\/locally advanced pancreatic cancer after preoperative chemotherapy and stereotactic body radiation therapy","volume":"9","author":"Chung","year":"2024","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.prro.2026.03.015_bib0058","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.semradonc.2025.08.003","article-title":"Optimal target volume delineation for pancreatic cancer: Triangulating what should be targeted","volume":"35","author":"Narang","year":"2025","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.prro.2026.03.015_bib0059","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF02924230","article-title":"Pancreatic cancer. Why patients die","volume":"7","author":"Douglass","year":"1990","journal-title":"Int J Pancreatol"},{"key":"10.1016\/j.prro.2026.03.015_bib0060","article-title":"Causes of death among patients with initially inoperable pancreas cancer after induction chemotherapy and ablative 5-fraction stereotactic magnetic resonance image guided adaptive radiation therapy","volume":"8","author":"Chuong","year":"2023","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.prro.2026.03.015_bib0061","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/COC.0000000000000518","article-title":"Pattern of marginal local failure in a phase II trial of neoadjuvant chemotherapy and stereotactic body radiation therapy for resectable and borderline resectable pancreas cancer","volume":"42","author":"Kharofa","year":"2019","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.prro.2026.03.015_bib0062","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.ijrobp.2024.10.026","article-title":"NRG oncology international consensus contouring atlas on target volumes and dosing strategies for dose-escalated pancreatic cancer radiation therapy","volume":"121","author":"Sanford","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2026.03.015_bib0063","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ijrobp.2025.03.049","article-title":"Feasibility of stereotactic body radiation therapy for pancreatic tumors abutting organs at risk using magnetic resonance guided adaptive radiation therapy","volume":"122","author":"D\u2019Souza","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850026001335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850026001335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:12:38Z","timestamp":1788174758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850026001335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1879850026001335"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2026.03.015","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adaptive Salvage Stereotactic Radiation for Locoregional Recurrence of Pancreatic Adenocarcinoma After Surgery","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2026.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Radiation Oncology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}